Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same.
Toor
Amir A
AA
Department of Internal Medicine, Virginia Commonwealth University Health Systems, Richmond, VA 23298-0157, USA. atoor@vcu.edu
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D008962:Models, Theoretical; D012008:Recurrence; D012074:Remission Induction
D000970:Antineoplastic Agents